|
Feb 16
|
Novartis, Roche’s Food Allergies Treatment Xolair Gets FDA Approval
|
|
Feb 16
|
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
|
|
Feb 16
|
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
|
|
Feb 16
|
Blueprint (BPMC) Q4 Earnings Beat, Stock Up as Ayvakit Shines
|
|
Feb 16
|
Freenome raises $254M to study cancer screening tests
|
|
Jan 16
|
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
|
|
Jan 16
|
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
|
|
Jan 16
|
European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
|
|
Jan 12
|
The Zacks Analyst Blog Highlights Roche, Netflix, NIKE, Uber, Technologies and Prologis
|
|
Jan 12
|
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
|
|
Jan 11
|
Top Research Reports for Roche, Netflix & NIKE
|
|
Jan 11
|
Renewables grew rapidly in 2023, but must grow faster still to meet climate change target, IEA says
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
Why Sarepta's (SRPT) Stock Price Moved Up 17% on Tuesday
|
|
Jan 10
|
Swiss Pharma Giants Who Missed Boat on Obesity Fight to Stay Relevant
|
|
Jan 9
|
How Roche aims to change the 'standard of care'
|
|
Jan 9
|
Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results
|
|
Jan 9
|
Should You Invest in Roche Holding AG (RHHBY)?
|
|
Jan 3
|
Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing
|
|
Jan 3
|
Roche joins startup Remix in bet on another way to drug RNA
|